Immunic to present MS drug data at Toronto conference
Tweet Send to a Friend
Immunic, Inc. (Nasdaq: IMUX) announced that four abstracts on its investigational drug vidofludimus calcium (IMU-838) have been accepted for presentation ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE




